4//SEC Filing
OPTIMER PHARMACEUTICALS INC 4
Accession 0001142576-13-000026
CIK 0001142576operating
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 6:08 PM ET
Size
7.8 KB
Accession
0001142576-13-000026
Insider Transaction Report
Form 4
AMPER LINDA E
SVP, Human Resources
Transactions
- Disposition to Issuer
Stock option (right to buy)
2013-10-24$1.37/sh−100,000$137,000→ 0 totalExercise: $11.41Exp: 2021-01-26→ Common stock (100,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2013-10-24$2.06/sh−30,000$61,800→ 0 totalExercise: $10.72Exp: 2023-02-26→ Common stock (30,000 underlying)
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 30, 2013 (the "Merger Agreement"), among Optimer Pharmaceuticals, Inc. ("Optimer"), Cubist Pharmaceuticals, Inc. ("Cubist"), and PDRS Corporation, each option was fully vested and converted into the right to receive a cash payment equal to the excess, if any, of $12.78 (the last reported sale price of a share of Optimer common stock on The NASDAQ Global Select Market on October 23, 2013) over such option's per share exercise price.
Documents
Issuer
OPTIMER PHARMACEUTICALS INC
CIK 0001142576
Entity typeoperating
Related Parties
1- filerCIK 0001142576
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 6:08 PM ET
- Size
- 7.8 KB